Catalogue number: | PA 05 0721004 |
Chemical name: | (3S,6R,7S,8S,12Z,15S,16E)-1,3,7,15-Tetrakis-{[tert-butyl(dimethyl)silyl]oxy}-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-dien-5-one |
CAS Number: |
193146-51-9 |
Category: | chiral standards,pharmaceutical standards,impurities,metabolites,fine chemicals |
Synonyms: | (7S,10R,11S,12S,19S,Z)-7,11-Bis((tert-butyldimethylsilyl)oxy)-2,2,3,3,8,8,10,12,16,21,21,22,22-tridecamethyl-19-((E)-1-(2-methylthiazol-4-yl)prop-1-en-2-yl)-4,20-dioxa-3,21-disilatricos-16-en-9-one; |
Molecular form: | C51H101NO5SSi4 |
Appearance: | Off-Yellow Oil |
Mol. Weight: | 952.77 |
Storage: | 2-8°C Refrigerator |
Shipping Conditions: | Ambient |
Applications: | An intermediate in the synthesis of Epothilones. Epothilones are polyketide natural products that inhibit cancer cells by a mechanism similar to paclitaxel, and also are effective against paclitaxel-resistant tumours. Epothilone D is in phase I clinical testing of in patients with advanced solid tumours. Epothilone D is a cytotoxic macrolide that stabilises malignant cells' microtubules and arrests mitosis, a characteristic it shares with other epothilones. They bind to the same hepatic sites as does paclitaxel (Taxol) in a 1:1 stoichiometric ratio of a, b-tubulin heterodimers. |
BTM: | NA |
(3S,6R,7S,8S,12Z,15S,16E)-1,3,7,15-Tetrakis-{[tert-butyl(dimethyl)silyl]oxy}-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-dien-5-one
In House ImpurityEnquire for (3S,6R,7S,8S,12Z,15S,16E)-1,3,7,15-Tetrakis-{[tert-butyl(dimethyl)silyl]oxy}-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)heptadeca-12,16-dien-5-one
Related Products
Search by Keywords – Buy 193146-51-9 | Purchase 193146-51-9 | Order 193146-51-9 | Enquire 193146-51-9 | Price of 193146-51-9 | 193146-51-9 Cost | 193146-51-9 Supplier | 193146-51-9 Distributor | 193146-51-9 Manufacturer | 193146-51-9 Exporter